Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 15 - Number 4
Graphical Abstract
Editorial
Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
, 15(4): 272 - 281Sandra Marques, Joana Fonseca, Patricia M.A. Silva and Hassan Bousbaa
DOI: 10.2174/1568009615666150302130010
Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound
, 15(4): 282 - 313Hesham G. Moussa, Ana M. Martins and Ghaleb A. Husseini
DOI: 10.2174/1568009615666150311100610
Experience with Androgen Deprivation Therapy for Prostate Cancer in Japan and Future Perspectives
, 15(4): 314 - 326Yasuhide Kitagawa, Satoru Ueno, Hiroyuki Konaka, Atsushi Mizokami, Shiro Hinotsu, Hideyuki Akaza and Mikio Namiki
DOI: 10.2174/156800961504150518112720
A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
, 15(4): 327 - 336Nick Ka Ming Yau, Andrew Yuon Fong, Hiu Fung Leung, Krista Roberta Verhoeft, Qin Ying Lim, Wai Yip Lam, Ian Chi Kei Wong and Vivian Wai Yan Lui
DOI: 10.2174/1568009615666150225123712
Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging
, 15(4): 337 - 351Weiqin Wang, Sarra Abbad, Zhenhai Zhang, Shu Wang, Jianping Zhou and Huixia Lv
DOI: 10.2174/1568009615666150211104524
Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts
, 15(4): 352 - 362Marina Mendiburu-Elicabe and Jon Gil-Ranedo
DOI: 10.2174/1568009615666150225123120
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
Center for Drug Discovery
University of Houston
Houston, TX
Biography
Biography of Ruiwen Zhang
Ruiwen Zhang is the Robert L. Boblitt Endowed Professor in Drug Discovery and Director of the Drug Discovery Institute at the University of Houston. With over 30 years of experience in the field of biomedical research, particularly in the area of clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH and DoD, and other agencies. He has published more than 230 papers, 2 books, and more than 50 invited reviews/book chapters as well as more than 180 meeting abstracts. For his outstanding contributions in pharmaceutical sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009. Dr. Zhang is recently elected as Fellow of National Academy of Inventors (2018).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net